Concert Pharmaceuticals, Inc. Announces Filing Of Its Annual Report On Form 10-K

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission.

A copy of the Annual Report on Form 10-K is available to be viewed or downloaded from the Investors & Media section of Concert’s website at www.concertpharma.com. Concert stockholders or other interested parties may obtain a hard copy of the Annual Report on Form 10-K, free of charge, by contacting Concert’s Investor Relations Department at: 99 Hayden Avenue, Suite 500, Lexington, MA 02421, or by email at: ir@concertpharma.com.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC